WO2004027086A1 - Procede de detection de microorganismes resistants a la meticilline - Google Patents
Procede de detection de microorganismes resistants a la meticilline Download PDFInfo
- Publication number
- WO2004027086A1 WO2004027086A1 PCT/FR2003/002788 FR0302788W WO2004027086A1 WO 2004027086 A1 WO2004027086 A1 WO 2004027086A1 FR 0302788 W FR0302788 W FR 0302788W WO 2004027086 A1 WO2004027086 A1 WO 2004027086A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- medium according
- microorganisms
- bromo
- chloro
- methicillin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/14—Streptococcus; Staphylococcus
Definitions
- the invention relates to a new gelled medium for detecting microorganisms resistant to methicillin, in which an antibiotic chosen from the group of cephalosporins, in particular second or third generation, is present, and a chromogenic agent carrying a chromophore released after hydrolysis with a enzyme active in said microorganisms.
- MRSA methicillin-resistant Staphylococcus aureus
- Agar growth media have been proposed supplemented with tobramycin or ofloxacin, either in bases which are not very discriminating (derived from
- the agar diffusion method is also used, for example Mueller Hinton agar, which consists of depositing paper discs impregnated with antibiotics on an agar seeded with the bacterium to be studied. A gradient of antibiotic concentration around each disc is established in the agar. After incubation, there is an inhibition halo around each disc which makes it possible to measure a diameter, which reflects the value of the MIC (minimum inhibition concentration, minimum concentration for which no growth of microorganisms is detected).
- Mueller Hinton agar which consists of depositing paper discs impregnated with antibiotics on an agar seeded with the bacterium to be studied. A gradient of antibiotic concentration around each disc is established in the agar. After incubation, there is an inhibition halo around each disc which makes it possible to measure a diameter, which reflects the value of the MIC (minimum inhibition concentration, minimum concentration for which no growth of microorganisms is detected).
- the present invention relates to an agar culture medium making it possible to detect microorganisms resistant to methicillin, and in particular staphylococci, in particular golden staphylococci, with good sensitivity and good specificity.
- the discriminating capacities of the chromogenic media are used, in combination with the properties of antibiotics of the family of cephalosporins of 2 nd or 3 rd generation, which make it possible to detect microorganisms resistant to methicillin.
- the invention therefore relates to a medium for the detection of microorganisms resistant to methicillin, comprising, in addition to nutrients allowing the growth of said microorganisms, at least one antibiotic chosen from the group of second or third generation cephalosporins, and a chromogenic agent. releasing a chromophore after hydrolysis with an active enzyme in said microorganisms.
- the culture media according to the invention allow direct detection of microorganisms resistant to methicillin, due to their growth on the medium according to the invention and the presence of the chromogenic agent (s), to define the nature of the microorganism. There is therefore no need for an additional step of confirming the nature of the microorganisms growing on the medium according to the invention.
- the media according to the invention allow the detection of bacteria resistant to methicillin, from a striated inoculum on a dish, while the majority of the methods of the prior art use a deposit of approximately 10 4 to 10 5 bacteria on agar.
- the media according to the invention can be used directly from a sample from a patient, or after an enrichment phase.
- cephalosporin is intended to denote the antibiotics of the cephalosporin family having a formula derived from the following formula (I):
- R2 is a group H, acetoxy-methyl, methyl-thiotetrazole, dimethyl-amino-ethyl-thiotetrazole, triazine, acetamino-pyridine (pyridinium), or pyridinium substituted by a carbamoyl, cyclo-pento-pyridinium, thiomethyl-acetoxy group -thiazole, RI is an amino-2-thiazole heterocycle, an ⁇ -piperazine-dione, an ⁇ -sulfo-phenyl, and R4 is an H group or an ⁇ -methoxy radical.
- R3 is an H group or an ⁇ -methoxy-imino group.
- the group R4 is hydrogen.
- Cephamycins are compounds in which the R4 group is an ⁇ -methoxy radical, protecting the ⁇ -lactam nucleus from hydrolysis by ⁇ -lactamases and correspond to the following formula:
- Oxacephems are compounds in which the sulfur atom of the cephem nucleus is replaced by an oxygen atom, and are considered to be derived from formula (I) presented above.
- the group R4 is an ⁇ -methoxy.
- a definition of the cephalosporins thus envisaged can be found in Binger (Mechanism of Action of Beta-lactams, (from the bacterial structure to the structure of the molecule), 1986 Roussel (Paris) editor, chapter III pages 47-62, and chapter IV pages 63-68), and in Richmond (Beta-lactam antibiotics (the background to their use as therapeutic agents), Hoechst Aktiengesellschaft, D- 6230 Frankfurt (Main) 80 publisher, 1981, chapter 3 pages 55- 65).
- second generation cephalosporins have a better effect than first generation cephalosporins against Gram negative bacteria and are more resistant to degradation by ⁇ -lactamases, third generation cephalosporins having a spectrum of even larger effect against Gram negative bacteria.
- cephalosporins we can cite: loracarbef, cefaclor, cefuroxime, cefprozil, cefoxitin (cefoxitan), cefamandole, cefotian, cefotetan, cefmetazole, cefocinide, ceforanide, cefpodoximefaxime, cefpodoxime, cefpodoxime cefmenoxime, cefodizime, cefoperazone, cefepime, cefpirome, cefsulfonide, cefetamete, ceftibutene, moxalactam, latamoxef and fiomoxef, especially in the form of (sodium) salts.
- said antibiotic is cefamandole.
- said antibiotic is chosen from the group of cephamicins (cefoxitin, cefotetan, cefmetazole, cefbupérazone, cefminox) and oxacephems (moxalactam, latamoxef or flomoxef).
- cephamicins cefoxitin, cefotetan, cefmetazole, cefbuperazone, cefminox
- oxacephems mixalactam, latamoxef or flomoxef.
- said antibiotic is cefoxitin.
- said antibiotic is cefmetazole.
- said antibiotic is moxalactam.
- said antibiotic is cefotetan.
- the antibiotic concentration in the medium according to the invention is preferably between 0.5 and 50 mg / 1, preferably 1.5 and 30 mg / 1, in particular 1.5 and 15 mg / 1.
- a stability of at least 2 months has been observed for a medium in accordance with the invention prepared with cefoxitin at a concentration of 5 mg / 1, added to the medium when the latter is at a temperature of 48 °. vs.
- the stability of the medium in accordance with the invention has been increased to at least 5 months when it has been prepared with cefmetazole at a concentration of 2.5 mg / 1, added to the medium when the latter is at a temperature of 48 ° C.
- stability of the medium is meant the capacity of the medium according to the invention to allow the selective detection of microorganisms resistant to methicillin, in particular golden staphylococci, for a given time, with the same reliability throughout the duration of the period.
- flomoxef another cephalosporin, flomoxef, has the ability to maintain its antibiotic activity when it is subjected to a temperature above 100 ° C (its resistance having even been verified by the inventors at 121 ° C).
- a temperature above 100 ° C makes it possible to produce a medium in accordance with the invention in the form of a single powder, which considerably limits the manipulations necessary to be carried out under sterile conditions for the preparation of any culture medium.
- the flomoxef can therefore be incorporated into the medium in preparation before heating which facilitates the preparation. This advantage is not negligible because it is likely to facilitate the task of any person having to prepare such environments, whatever their experience in the matter.
- said microorganisms are staphylococci, and a chromogenic agent is preferably used chosen from the group consisting of 5-bromo 6-chloro 3-indoxyl phosphate and 5-bromo 4-chloro 3-indoxyl glucoside, as well as described in application WO 00/53799.
- Culture media for S. aureus are known and described in particular in the manual "Oxo ⁇ d Unipath Limited", Wade Road, Basingstoke, Hampshire, RG24 OPW, England. It can be, for example, "Nutrient Agar Oxo ⁇ d CM3", a medium essentially based on yeast, peptone and agar extracts.
- said culture medium contains both 5-bromo 6-chloro 3-indoxyl phosphate and 5-bromo 4-chloro 3-indoxyl glucoside.
- the media according to the present invention will preferably contain from 0.01 to 0.50 g / l, in particular from 0.05 to 0.40 g / l of 5-bromo 6-chloro 3-indoxyl phosphate, preferably from 0.01 to 0.20 g / 1 of 5-bromo 4-chloro 3-indoxyl glucoside, preferably from 0.01 to 0.20 g / 1 of 5-bromo 4-chloro 3-indoxyl galactoside, preferably of 0.01 to 0.20 g / 1 of 5-bromo 4-chloro 3-indoxyl glucuronide.
- the culture medium according to the invention further comprises at least one of the following two chromogenic agents: 5-bromo 4-chloro 3-indoxyl galactoside and 5-bromo 4-chloro 3- indoxyl glucuronide.
- said medium also contains deferoxamine.
- deferoxamine makes it possible to inhibit Staphylococcus epidermis without inhibiting Staphylococcus aureus, the concentration used will preferably be between 0.01 and 0.10 g / l.
- the medium according to the invention also contains a glycopeptide antibiotic chosen from the group consisting of vancomycin, teicoplanin and avoparcin and their mixtures, to detect microorganisms resistant to both methicillin and vancomycin.
- a glycopeptide antibiotic chosen from the group consisting of vancomycin, teicoplanin and avoparcin and their mixtures, to detect microorganisms resistant to both methicillin and vancomycin.
- the inventors have shown that it is not necessary to have a high osmotic charge in the culture medium.
- the culture medium of the invention is also functional with a sodium concentration of less than 3 %, and equal to about 2-2.5%.
- the incubation conditions can be adapted as a function of the quantity of sodium chloride in the medium (duration of incubation, more or less high temperature, etc.).
- the invention also relates to the use of a medium according to the invention for the detection of microorganisms resistant to methicillin.
- the invention also relates to a method for detecting microorganisms resistant to methicillin in a sample, comprising the steps consisting in: inoculating a medium according to the invention with said sample or an inoculum from said sample, - incubating said medium in conditions allowing the growth of said microorganisms, detecting, on said medium, the presence of said microorganisms resistant to methicillin, by the presence of colored colonies.
- incubation conditions are known to those skilled in the art, and incubation at temperatures between 25 ° C and 42 ° C, preferably between 30 ° C and 38 ° C, is generally used.
- the incubation times are conventional (approximately 24 hours).
- the medium according to the invention makes it possible in particular to easily detect metapillin-resistant staphylococci, by reducing the analysis time.
- the combination of the antibiotics chosen within the framework of the invention and the agents Chromogens in fact make it possible to reduce the number of false positives and false negatives, and thus to reduce the need to carry out additional analyzes.
- composition of a medium according to the invention for the detection of S. aureus resistant to methicillin
- Oxacillin (6 mg / ml) or cefoxitin (5 mg / 1) is added to this medium, after autoclaving, before the medium is solid (when it is at a temperature of approximately 45 ° C).
- This medium contains 5-bromo 6-chloro 3-indoxyl phosphate and 5-bromo 4-chloro 3-indoxyl glucoside, allowing the specific detection of golden staphylococci (purple coloration of colonies), as well as 5-bromo 4-chloro 3-indoxyl galactoside and 5-bromo 4-chloro 3-indoxyl glucuronide, to color the other microorganisms that may be present in the inoculum.
- AR4295 MetiS strain sensitive to methicillin
- AR4297 MetiR strain resistant to methicillin (homogeneous)
- MRhet strain resistant to methicillin (heterogeneous)
- Z252 strain resistant to methicillin, homogeneous, low level of resistance
- the petri dishes are inoculated with bacterial cultures by striating the dishes, to observe the growth of isolated bacteria, after incubation at 37 ° C. for 24 hours.
- the growing bacteria give purple colonies on the culture medium, confirming that the microorganisms are golden staphylococci.
- the medium according to the invention makes it possible to directly detect golden staphylococci resistant to methicillin, including heterogeneous strains or with a low level of resistance, due to the combination of the growth of bacteria and the coloration of the colonies.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2499216A CA2499216C (fr) | 2002-09-23 | 2003-09-23 | Procede de detection de microorganismes resistants a la meticilline |
US10/528,824 US7632657B2 (en) | 2002-09-23 | 2003-09-23 | Method of detecting meticillin-resistant microorganisms |
DK03773805.1T DK1543147T4 (da) | 2002-09-23 | 2003-09-23 | Fremgangsmåde til påvisning af methicillin-resistente Staphylococcus aureus |
DE60310583T DE60310583T3 (de) | 2002-09-23 | 2003-09-23 | Verfahren zum nachweis von methicillinresistenten staphylococcus aureus |
JP2004537238A JP2006500020A (ja) | 2002-09-23 | 2003-09-23 | メチシリン耐性微生物の検出方法 |
AU2003282185A AU2003282185A1 (en) | 2002-09-23 | 2003-09-23 | Method of detecting meticillin-resistant micro-organisms |
EP03773805A EP1543147B2 (fr) | 2002-09-23 | 2003-09-23 | Procede de detection de staphylococcus aureus resistants a la meticilline |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR02/11718 | 2002-09-23 | ||
FR0211718A FR2844807B1 (fr) | 2002-09-23 | 2002-09-23 | Procede de detection de microorganismes resistants a la meticilline |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004027086A1 true WO2004027086A1 (fr) | 2004-04-01 |
Family
ID=31970887
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2003/002788 WO2004027086A1 (fr) | 2002-09-23 | 2003-09-23 | Procede de detection de microorganismes resistants a la meticilline |
Country Status (12)
Country | Link |
---|---|
US (1) | US7632657B2 (fr) |
EP (1) | EP1543147B2 (fr) |
JP (6) | JP2006500020A (fr) |
CN (1) | CN100475954C (fr) |
AT (1) | ATE348895T1 (fr) |
AU (1) | AU2003282185A1 (fr) |
CA (1) | CA2499216C (fr) |
DE (1) | DE60310583T3 (fr) |
DK (1) | DK1543147T4 (fr) |
ES (1) | ES2277126T5 (fr) |
FR (1) | FR2844807B1 (fr) |
WO (1) | WO2004027086A1 (fr) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004063391A1 (fr) * | 2003-01-10 | 2004-07-29 | Becton, Dickinson And Company | Methode de detection de resistance a un antibiotique dans des micro-organismes |
FR2882370A1 (fr) * | 2005-02-22 | 2006-08-25 | Alain Rambach | Detection d'une souche de microorganismes dans un echantillon liquide |
JP2008529514A (ja) * | 2005-02-10 | 2008-08-07 | ビオメリュー | 耐性微生物の特異的検出用の培地 |
FR2949119A1 (fr) * | 2009-08-13 | 2011-02-18 | Biomerieux Sa | Milieu reactionnel pour les bacteries staphylococcus aureus resistantes a la meticilline (mrsa) |
WO2011080305A1 (fr) | 2009-12-31 | 2011-07-07 | Bio-Rad Pasteur | Milieu de culture pour le criblage ou l'enrichissement de s. aureus résistant à la méthicilline |
US8415115B2 (en) | 2008-10-08 | 2013-04-09 | Biomerieux | Reaction medium for methicillin-resistant Staphylococcus aureus (MRSA) bacteria |
US8497086B2 (en) | 2009-08-13 | 2013-07-30 | Biomereux | Reaction medium for methicillin-resistant Staphylococcus aureus (MRSA) bacteria |
US8741597B2 (en) | 2008-10-08 | 2014-06-03 | bioMérieux | Reaction medium for methicillin-resistant Staphylococcus aureus |
US8828682B2 (en) | 2008-12-09 | 2014-09-09 | 3M Innovative Properties Company | Methods and articles for detecting hemolytic microorganisms |
EP2981619B1 (fr) * | 2013-04-03 | 2020-01-01 | bioMérieux | Utilisation d'au moins un substrat de phosphatase chromogène et/ou fluorogène pour la détection et/ou le dénombrement d'entérobactéries dans un échantillon |
US10782291B2 (en) | 2006-12-19 | 2020-09-22 | Becton Dickinson And Company | Chromogenic medium for the detection and identification of Vancomycin resistant enterococci and method therefor |
US11001873B2 (en) | 2012-12-28 | 2021-05-11 | Biomerieux | Microorganism detection method comprising at least one alkyl(thio)glycoside |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2844807B1 (fr) | 2002-09-23 | 2005-11-11 | Rambach Alain | Procede de detection de microorganismes resistants a la meticilline |
FR2924127B1 (fr) * | 2007-11-26 | 2013-02-08 | Biomerieux Sa | Milieu reactionnel pour la detection et/ou l'identification de staphyloccocus aureus |
GB0814099D0 (en) * | 2008-08-01 | 2008-09-10 | Oxoid Ltd | Method of screening for pathogens |
US20110171683A1 (en) * | 2008-08-21 | 2011-07-14 | Mach Patrick A | Methods and compositions for enumerating antibiotic-resistant microorganisms |
US8609364B2 (en) * | 2009-05-07 | 2013-12-17 | bioM{tilde over (e)}rieux, Inc. | Methods for antimicrobial resistance determination |
WO2011060222A2 (fr) | 2009-11-13 | 2011-05-19 | Beckman Coulter, Inc. | Systèmes et procédés destinés à détecter la présence d'un état biologique en utilisant un groupement |
RU2452774C1 (ru) * | 2011-01-31 | 2012-06-10 | Михаил Иосифович Коган | Способ определения бактериологической обсемененности мочи, секрета предстательной железы и эякулята |
DE102011017136B4 (de) | 2011-02-24 | 2016-03-10 | Guenther Bionics GmbH | Luftventil |
WO2020018462A1 (fr) | 2018-07-16 | 2020-01-23 | Brown University | Substrat de bêta-lactamase chromogène |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07181A (ja) * | 1992-06-18 | 1995-01-06 | Kyokuto Seiyaku Kogyo Kk | 多剤耐性ブドウ球菌を選択的に培養するための培地 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8518422D0 (en) * | 1985-07-22 | 1985-08-29 | Beecham Group Plc | Compounds |
JPH05227992A (ja) * | 1992-02-21 | 1993-09-07 | Showa Yakuhin Kako Kk | 細菌培養用培地 |
GB9222700D0 (en) * | 1992-10-29 | 1992-12-09 | Smithkline Beecham Plc | Chemical compounds |
JPH0813266B2 (ja) | 1992-11-16 | 1996-02-14 | 幸子 佐竹 | メチシリン耐性黄色ブドウ球菌の選択および鑑別分離培地 |
FR2708285B1 (fr) | 1993-07-28 | 1995-10-20 | Rambach Alain | Procédé d'identification de microorganismes avec un milieu supplémenté en hydrate de carbone. |
US5443963A (en) | 1994-01-31 | 1995-08-22 | Minnesota Mining And Manufacturing Company | Method for detecting staphylococci |
US5650290A (en) * | 1994-04-01 | 1997-07-22 | Hach Company | Method & Medium for use in detecting E. coli and total coliforms |
US5883074A (en) * | 1995-02-08 | 1999-03-16 | Microcide Pharmaceuticals, Inc. | Potentiators of antibacterial agents |
US5627045A (en) * | 1995-04-12 | 1997-05-06 | Biolog, Inc. | Multi-test format with gel-forming matrix for characterization of microorganisms |
US5882882A (en) * | 1995-04-12 | 1999-03-16 | Biolog, Inc. | Gel matrix with redox purple for testing and characterizing microorganisms |
CA2268930A1 (fr) * | 1996-10-17 | 1998-04-30 | Smithkline Beecham P.L.C. | Derives de beta-thiopropionyl-aminoacide et utilisation de ces derniers en tant qu'inhibiteurs de beta-lactamase |
CA2276097A1 (fr) * | 1996-12-25 | 1998-07-09 | Hideaki Hanaki | Composes du cepheme |
FR2790765B1 (fr) | 1999-03-11 | 2003-01-31 | Alain Rambach | Milieu chromogene de detection de staphylococcus aureus. |
US6221859B1 (en) * | 1999-08-27 | 2001-04-24 | Merck & Co., Inc. | Carbapenem antibacterial compositions and methods of the treatment |
US6130057A (en) * | 1999-09-28 | 2000-10-10 | Becton, Dickinson And Company | Method for differentiating microorganisms in a sample |
US6696239B1 (en) * | 2000-04-20 | 2004-02-24 | Biolog, Inc. | Comparative phenotype analysis for assessment of biological active compounds such as antimicrobials |
FR2844807B1 (fr) | 2002-09-23 | 2005-11-11 | Rambach Alain | Procede de detection de microorganismes resistants a la meticilline |
AU2004204446A1 (en) * | 2003-01-10 | 2004-07-29 | Becton, Dickinson And Company | Method of detecting antibiotic resistance in microorganisms |
-
2002
- 2002-09-23 FR FR0211718A patent/FR2844807B1/fr not_active Expired - Lifetime
-
2003
- 2003-09-23 DK DK03773805.1T patent/DK1543147T4/da active
- 2003-09-23 AT AT03773805T patent/ATE348895T1/de not_active IP Right Cessation
- 2003-09-23 DE DE60310583T patent/DE60310583T3/de not_active Expired - Lifetime
- 2003-09-23 EP EP03773805A patent/EP1543147B2/fr not_active Expired - Lifetime
- 2003-09-23 JP JP2004537238A patent/JP2006500020A/ja active Pending
- 2003-09-23 CN CNB03822691XA patent/CN100475954C/zh not_active Expired - Lifetime
- 2003-09-23 WO PCT/FR2003/002788 patent/WO2004027086A1/fr active IP Right Grant
- 2003-09-23 US US10/528,824 patent/US7632657B2/en not_active Expired - Lifetime
- 2003-09-23 CA CA2499216A patent/CA2499216C/fr not_active Expired - Lifetime
- 2003-09-23 ES ES03773805T patent/ES2277126T5/es not_active Expired - Lifetime
- 2003-09-23 AU AU2003282185A patent/AU2003282185A1/en not_active Abandoned
-
2009
- 2009-03-31 JP JP2009084877A patent/JP2009183298A/ja not_active Withdrawn
-
2013
- 2013-11-01 JP JP2013228133A patent/JP2014060995A/ja not_active Withdrawn
-
2016
- 2016-04-27 JP JP2016089021A patent/JP2016174610A/ja active Pending
-
2019
- 2019-02-08 JP JP2019021241A patent/JP7107868B2/ja not_active Expired - Lifetime
-
2022
- 2022-02-04 JP JP2022016328A patent/JP2022068228A/ja active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07181A (ja) * | 1992-06-18 | 1995-01-06 | Kyokuto Seiyaku Kogyo Kk | 多剤耐性ブドウ球菌を選択的に培養するための培地 |
Non-Patent Citations (5)
Title |
---|
AYERS L W ET AL: "CEFOTETAN A NEW CEPHAMYCIN COMPARISON OF IN-VITRO ANTI MICROBIAL ACTIVITY WITH OTHER CEPHEMS BETA LACTAMASE STABILITY AND PRELIMINARY RECOMMENDATIONS FOR DISC DIFFUSION TESTING", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 22, no. 5, 1982, pages 859 - 877, XP008017736, ISSN: 0066-4804 * |
DATABASE WPI Section Ch Week 199511, Derwent World Patents Index; Class B04, AN 1995-077141, XP002243919 * |
JONES R N ET AL: "IN-VITRO ANTI MICROBIAL ACTIVITY EVALUATION OF CEFODIZIME HR-221 A NEW SEMI SYNTHETIC CEPHALOSPORIN", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 20, no. 6, 1981, pages 760 - 768, XP008017735, ISSN: 0066-4804 * |
KLUYTMANS JAN ET AL: "Performance of CHROMagar selective medium and oxacillin resistance screening agar base for identifying Staphylococcus aureus and detecting methicillin resistance.", JOURNAL OF CLINICAL MICROBIOLOGY. UNITED STATES JUL 2002, vol. 40, no. 7, July 2002 (2002-07-01), pages 2480 - 2482, XP001157563, ISSN: 0095-1137 * |
MERLINO JOHN ET AL: "New chromogenic identification and detection of Staphylococcus aureus and methicillin-resistant S. aureus.", JOURNAL OF CLINICAL MICROBIOLOGY, vol. 38, no. 6, June 2000 (2000-06-01), pages 2378 - 2380, XP001157564, ISSN: 0095-1137 * |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004063391A1 (fr) * | 2003-01-10 | 2004-07-29 | Becton, Dickinson And Company | Methode de detection de resistance a un antibiotique dans des micro-organismes |
JP2008529514A (ja) * | 2005-02-10 | 2008-08-07 | ビオメリュー | 耐性微生物の特異的検出用の培地 |
US11111518B2 (en) | 2005-02-10 | 2021-09-07 | Biomerieux | Medium for the specific detection of resistant microorganisms |
US10494658B2 (en) | 2005-02-10 | 2019-12-03 | Biomerieux Sa | Medium for the specific detection of resistant microorganisms |
FR2882370A1 (fr) * | 2005-02-22 | 2006-08-25 | Alain Rambach | Detection d'une souche de microorganismes dans un echantillon liquide |
WO2006089889A1 (fr) * | 2005-02-22 | 2006-08-31 | Alain Rambach | Detection d'une souche de microorganismes dans un echantillon liquide |
US11604190B2 (en) | 2006-12-19 | 2023-03-14 | Becton Dickinson And Company | Chromogenic medium for the detection and identification of vancomycin resistant enterococci and method therefor |
US10782291B2 (en) | 2006-12-19 | 2020-09-22 | Becton Dickinson And Company | Chromogenic medium for the detection and identification of Vancomycin resistant enterococci and method therefor |
US8415115B2 (en) | 2008-10-08 | 2013-04-09 | Biomerieux | Reaction medium for methicillin-resistant Staphylococcus aureus (MRSA) bacteria |
US8741597B2 (en) | 2008-10-08 | 2014-06-03 | bioMérieux | Reaction medium for methicillin-resistant Staphylococcus aureus |
US8828682B2 (en) | 2008-12-09 | 2014-09-09 | 3M Innovative Properties Company | Methods and articles for detecting hemolytic microorganisms |
US8497086B2 (en) | 2009-08-13 | 2013-07-30 | Biomereux | Reaction medium for methicillin-resistant Staphylococcus aureus (MRSA) bacteria |
WO2011018589A3 (fr) * | 2009-08-13 | 2011-04-07 | bioMérieux | Milieu reactionnel pour les bacteries staphylococcus aureus resistantes a la meticilline (mrsa) |
FR2949119A1 (fr) * | 2009-08-13 | 2011-02-18 | Biomerieux Sa | Milieu reactionnel pour les bacteries staphylococcus aureus resistantes a la meticilline (mrsa) |
US9434978B2 (en) | 2009-12-31 | 2016-09-06 | Bio-Rad Innovations | Culture medium for screening or enrichment of methicillin-resistant S. aureus |
KR101824588B1 (ko) | 2009-12-31 | 2018-02-01 | 바이오-라드 이노베이션스 | 메티실린-저항성 s. 아우레우스의 스크리닝 또는 농축을 위한 배양 배지 |
WO2011080305A1 (fr) | 2009-12-31 | 2011-07-07 | Bio-Rad Pasteur | Milieu de culture pour le criblage ou l'enrichissement de s. aureus résistant à la méthicilline |
US11001873B2 (en) | 2012-12-28 | 2021-05-11 | Biomerieux | Microorganism detection method comprising at least one alkyl(thio)glycoside |
EP2981619B1 (fr) * | 2013-04-03 | 2020-01-01 | bioMérieux | Utilisation d'au moins un substrat de phosphatase chromogène et/ou fluorogène pour la détection et/ou le dénombrement d'entérobactéries dans un échantillon |
US10808275B2 (en) | 2013-04-03 | 2020-10-20 | bioMérieux | Use of at least one chromogenic and/or fluorogenic phosphatase substrate for the detection and/or enumeration of enterobacteria in a sample |
Also Published As
Publication number | Publication date |
---|---|
JP2019088314A (ja) | 2019-06-13 |
JP2006500020A (ja) | 2006-01-05 |
JP2022068228A (ja) | 2022-05-09 |
EP1543147A1 (fr) | 2005-06-22 |
EP1543147B2 (fr) | 2011-03-16 |
ES2277126T3 (es) | 2007-07-01 |
JP2009183298A (ja) | 2009-08-20 |
FR2844807B1 (fr) | 2005-11-11 |
FR2844807A1 (fr) | 2004-03-26 |
DK1543147T4 (da) | 2011-06-14 |
DE60310583T2 (de) | 2007-10-04 |
CA2499216C (fr) | 2010-05-18 |
DE60310583D1 (de) | 2007-02-01 |
ES2277126T5 (es) | 2011-05-11 |
ATE348895T1 (de) | 2007-01-15 |
US7632657B2 (en) | 2009-12-15 |
CN100475954C (zh) | 2009-04-08 |
CN1685061A (zh) | 2005-10-19 |
JP2016174610A (ja) | 2016-10-06 |
DE60310583T3 (de) | 2012-09-27 |
JP2014060995A (ja) | 2014-04-10 |
AU2003282185A1 (en) | 2004-04-08 |
US20060035309A1 (en) | 2006-02-16 |
CA2499216A1 (fr) | 2004-04-01 |
JP7107868B2 (ja) | 2022-07-27 |
DK1543147T3 (da) | 2007-02-12 |
EP1543147B1 (fr) | 2006-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2499216C (fr) | Procede de detection de microorganismes resistants a la meticilline | |
Cui et al. | Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus | |
EP2344663B1 (fr) | Milieu reactionnel pour les bacteries staphylococcus aureus | |
EP2465939B1 (fr) | Milieux pour la détection spécifique de microorganismes résistants | |
EP1789573A1 (fr) | Procede de detection de streptococcus agalactiae en utilisant l'activite alpha-glucosidase | |
EP1334206B1 (fr) | Procede et milieu de detection/identification de microorganismes a activite esterase et/ou osidase et/ou peptidase et/ou sulfatase et/ou phosphatate | |
EP2344662B1 (fr) | Milieu reactionnel pour les bacteries staphylococcus aureus resistantes a la meticilline (mrsa) | |
WO2011012790A1 (fr) | Milieux pour la detection specifique de bacteries gram negatives resistantes aux betalactamines | |
WO2004063391A1 (fr) | Methode de detection de resistance a un antibiotique dans des micro-organismes | |
EP1789575A2 (fr) | Procede de detection de streptococcus agalactiae en utilisant l'activite esterase | |
FR2881754A1 (fr) | Milieux pour la detection specifique de micro-organismes resistants | |
EP2464742B1 (fr) | Milieu reactionnel pour les bacteries staphylococcus aureus resistantes a la meticilline (mrsa) | |
FR2921670A1 (fr) | Milieu de culture specifique pour la croissance, la detection, l'identification et/ou la numerotation des bacteries staphylocoques a coagulase positive. | |
Maruyama et al. | Novel Mechanism of Antibiotic Resistance | |
WO2015155018A1 (fr) | Procédé de détection et d`identification de clostridium difficile |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2499216 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2006035309 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004537238 Country of ref document: JP Ref document number: 2003822691X Country of ref document: CN Ref document number: 10528824 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003773805 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003773805 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 10528824 Country of ref document: US |
|
WWG | Wipo information: grant in national office |
Ref document number: 2003773805 Country of ref document: EP |